COVID-19 pneumonia and the appropriate use of antibiotics

Lancet Glob Health. 2020 Dec;8(12):e1453-e1454. doi: 10.1016/S2214-109X(20)30444-7. Epub 2020 Nov 11.

Authors

Amy Sarah Ginsburg¹, Keith P Klugman²

Affiliations

¹ Clinical Trials Center, University of Washington, Seattle, WA 98115, USA. Electronic address: [email protected].
² Bill & Melinda Gates Foundation, Seattle, WA, USA.

No abstract available

MeSH terms

Anti-Bacterial Agents / adverse effects
Anti-Bacterial Agents / therapeutic use*
Bacterial Infections / diagnosis
Bacterial Infections / drug therapy*
Bacterial Infections / etiology
Bacterial Infections / microbiology
COVID-19 / complications*
COVID-19 / virology
Coinfection / diagnosis
Coinfection / drug therapy*
Coinfection / microbiology
Coronavirus Infections
Drug Resistance, Microbial*
Humans
Pandemics
Pneumonia / drug therapy*
Pneumonia / etiology
Pneumonia / microbiology
Pneumonia / virology
SARS-CoV-2

Substances

Anti-Bacterial Agents